17 results about "Expectorant" patented technology

This invention discloses an automatic control method and system for a MI-E expectorant machine, comprising: analyzing real-time respiratory data of a patient during the use of the expectorant machine to determine the applicable operating mode of the expectorant machine; diagnosing the consistency between the current operating mode of the expectorant machine and the applicable operating mode, wherein, if the diagnosis result is inconsistent, a working mode switching command is generated to switch the current operating mode of the expectorant machine to the applicable operating mode; or, if the diagnosis result is consistent, a treatment parameter adjustment command is generated to optimize the treatment parameters corresponding to the current operating mode of the expectorant machine. This invention achieves automatic control of the MI-E expectorant machine, effectively improving treatment safety and efficiency.

The invention discloses traditional Chinese medicine instant granules as well as a preparation method and application thereof. The traditional Chinese medicine instant granules are prepared from the following raw materials in parts by mass: 20-60 parts of traditional Chinese medicine components, 60-200 parts of a filling agent, 20-60 parts of a disintegrating agent and 5-30 parts of an adhesive. Different from traditional soluble granules, on one hand, the moisturizing-free instant granules are used for oral administration without a large amount of solvent, can be quickly dissolved in a very small amount of water, and can be almost completely dissolved within 5 seconds to form tiny granules; on the other hand, saliva irritants are not needed. The traditional Chinese medicine instant granules take traditional Chinese medicines as medicinal components, can contain various natural herbaceous plant micro powder or extracts, such as platycodon grandiflorum, liquorice and other components with the effects of relieving cough, eliminating phlegm, diminishing inflammation, easing pain and the like, and can directly act on the throat mucosa; and the ginseng, the astragalus membranaceus and other components with the effects of regulating immunity, tonifying middle-Jiao and Qi and the like can be quickly dissolved and then effectively absorbed.

1. The name of this design product: Expectorant. 2. Purpose of this design product: This design product is used for medical devices. 3. The key point of the design of this product lies in its shape. 4. The picture or photo that best illustrates the design points: three-dimensional picture.

The invention discloses a synephrine organic salt as well as a preparation method and application thereof. The synephrine and the pentacyclic triterpenoid organic acid react to generate the synephrine organic salt, and the pharmacodynamic experiment result shows that compared with the original single effective component, the synephrine organic salt has a synergistic effect, has better effects of relieving cough, eliminating phlegm and relieving asthma, is simple in synthetic route and has certain water solubility, and the synephrine organic salt can be used for preparing the medicine for treating cough and asthma. The compound preparation can be replaced to become a new medicine with clear active ingredients, definite curative effect and controllable quality.

The utility model relates to a back patting sputum excretion device which comprises an upper garment body, a rectangular shell and a vibration unit. Firstly, the rectangular backrest is attached to the back of a patient, the two shoulder straps are erected on the upper shoulders, the patient wears the upper garment body, the two vibration units correspond to the positions of the backs of two lung pieces of the patient respectively, the multiple driving pieces start to work, the driving pieces drive the telescopic rods to do repeated telescopic motion, and the telescopic rods beat the backs of the lung pieces rhythmically; sputum is promoted to move from an airway to a position where the sputum can be discharged more easily in a vibration mode, in addition, vibration with specific frequency and strength is generated, secretions in the airway can be effectively loosened and moved, and the secretions can be more easily coughed out or sucked out.

The application discloses a preparation process of effervescent granules of a composition containing phenylephrine hydrochloride, which is prepared by taking phenylephrine hydrochloride as a main active ingredient, and by adding antiallergic agents, expectorants, antitussives, antipyretics, anti-inflammatory agents and combinations thereof. In order to prevent degradation of phenylephrine hydrochloride, the phenylephrine hydrochloride is first wrapped with PEG together with an alkali source, and then mixed with other components to prepare the effervescent granules. The effervescent granules prepared by the method have the advantages of high drug stability, rapid effect, high bioavailability, convenient carrying and low cost, and are suitable for children, the elderly and patients who cannot swallow solid preparations.

The invention relates to a herbal preparation in the form of film-coated tablets for the supportive treatment of allergic rhinitis and sinusitis, and a process for preparing such a preparation. The preparation according to the invention contains herbal extracts obtained from a mixture of medicinal herbs including Bupleurum root (Radix Bupleurum), Platycodon grandiflorus root (Radix Platycodi grandiflori), Xanthium strumarium fruit (Fructus Xanthii strumarii), Magnolia officinalis flower (Flos Magnoliae), and Oroxylum indicum bark (Cortex Oroxyli indici), in which each herb is used in appropriate amounts to create synergistic anti-inflammatory, anti-allergic, decongestant, expectorant, and immune-enhancing effects on the respiratory mucosa. The preparation also includes a film-coating system containing a film-forming polymer, plasticizer, and coloring agent, along with tablet-forming excipients such as preservatives, fillers, stabilizers, and anti-caking agents in appropriate proportions to create a highly stable film-coated tablet.The preparation according to the invention has the advantages of preserving the active ingredients of the medicinal herbs, increasing stability, improving bioavailability, being convenient to use, and contributing to enhancing the effectiveness of supporting the treatment of symptoms of allergic rhinitis and sinusitis. It is also safe for long-term use because the preparation contains herbal extracts of natural origin that have been used for a long time in traditional medicine, and does not contain synthetic vasoconstrictors, corticosteroids, or antibiotics. In addition, the extraction and purification process helps remove impurities and reduce irritating components, thereby limiting the risk of unwanted side effects with prolonged use.

1. Name of the product in this design: Non-invasive expectorant machine. 2. Purpose of this design: For the treatment of cough and phlegm. 3. The key design features of this product are the combination of shape and pattern. 4. The image or photograph that best illustrates the design's key points: a 3D model.

This invention relates to the field of compound essential oils of traditional Chinese medicine, and particularly to a compound essential oil of traditional Chinese medicine for the adjuvant intervention against Streptococcus pneumoniae and its preparation method. The raw materials include the following by weight: 3-8 parts of patchouli essential oil; 2-6 parts of clove essential oil; 2-5 parts of costus root essential oil; 2-6 parts of nard essential oil; 3-7 parts of calamus essential oil; 1-4 parts of asarum essential oil; 3-8 parts of peppermint essential oil; 2-6 parts of artemisia essential oil; 3-7 parts of eupatorium essential oil; 45-80 parts of base oil; 2-5 parts of solubilizer; and 1-3 parts of penetration enhancer. This invention addresses the core issues of "respiratory inflammation, sputum accumulation, and decreased body defense" caused by Streptococcus pneumoniae. Through the scientific formulation of active molecules from nine kinds of Chinese herbal essential oils, a comprehensive synergistic system is formed, which has the functions of "antibacterial and antiviral, anti-inflammatory and lung-clearing, expectorant and cough-relieving, and enhanced defense." It features strong synergistic activity of active molecules, high specificity, high retention and utilization rate of active molecules, safe and convenient use, wide applicability, and simple preparation process.

The invention discloses a biological activity detection method for phlegm-eliminating related drug effects of different processed decoction pieces of pinellia ternate, and relates to the technical field of traditional Chinese medicines. The biological activity detection method comprises the following steps: extracting to-be-detected rhizoma pinelliae processed decoction pieces with water to obtain a test solution; carrying out mixed reaction on the test solution and MUC5AC protein to obtain a reaction solution; and detecting the content of MUC5AC protein in the reaction liquid, and calculating to obtain the in-vitro inhibition rate of the processed decoction pieces of pinellia ternate to be detected on the MUC5AC protein. According to the invention, the inhibition rate of different processed pinellia ternate products on MUC5AC is detected in vitro, so that an objective quantitative index is provided for the clinical phlegm eliminating effect and quality control of the pinellia ternate products, and the safe and effective clinical medication can be guaranteed.

The present invention relates to the pharmaceutical technology. Keratin CF2, methods for producing the same, pharmaceutical compositions containing the same and the use thereof are disclosed, and the present invention particularly relates to keratin CF2, nucleic acid molecules encoding the keratin CF2, expression vectors containing the nucleic acid molecule, host cells containing the expression vector or in which the nucleic acid molecule is incorporated into the genome, methods for producing the keratin CF2, pharmaceutical compositions containing the keratin CF2, and the use of the keratin CF2, nucleic acid molecules, expression vectors, host cells or pharmaceutical compositions in the manufacture of antipyretics, analgesics, antitussives, expectorants, anticonvulsants, antiepileptics, antihypertensives, anti-inflammatorys or antivirals.

This invention discloses an aromatherapy breathing balm and its preparation method. The balm contains compound essential oils: orange peel, tea tree, ravensara leaf, perilla, ginger, sandalwood, marjoram, and rosemary; phase A: aster extract and poria cocos extract; and phase B: sweet almond oil, olive emulsified wax, beeswax, and magnolia bark extract. The resulting cream has a uniform texture and a natural plant aroma. This aromatherapy breathing balm combines multiple compound essential oils and traditional Chinese medicine extracts with antitussive, expectorant, and phlegm-reducing effects, and employs a natural preservative system. It is convenient to use, has good stability, low side effects, is safe and non-irritating, and is suitable for adults and children to relieve cough, asthma, and excessive phlegm symptoms. When using, apply it to the skin, or take 1-2g, heat it in water, and inhale the resulting steam.

This invention discloses a medicinal and edible herbal composition with expectorant and nodule-dispersing effects and its preparation method, belonging to the technical field of medicinal and edible herbal compositions. The composition comprises 10-30 parts oyster shell, 10-20 parts tangerine peel, 10-20 parts Poria cocos, 10-20 parts bergamot, 8-18 parts honeysuckle, and 10-30 parts houttuynia cordata. A preferred ratio is 30 parts oyster shell, 15 parts tangerine peel, 15 parts Poria cocos, 15 parts bergamot, 9 parts honeysuckle, and 30 parts houttuynia cordata. Honey and other medicinal and edible excipients can be added. The preparation involves raw material pretreatment, volatile oil extraction, decoction, concentration, molding, and sterilization steps, and can be made into various dosage forms such as powder and granules. The raw materials used in this invention are all food and medicine homologous ingredients, which are safe for long-term use. The formula follows the theory of "softening and dispersing nodules, regulating qi and resolving phlegm, clearing heat and detoxifying". It improves the pathological microenvironment of nodules through related signaling pathways, and can effectively promote the shrinkage or dissipation of benign lung nodules, thyroid nodules and breast nodules. The preparation process is simple and has broad application prospects.

To provide a cold syrup comprising a herbal medicine along with an antipyretic analgesic, an antihistamine, an antitussive, and an expectorant, which suppresses precipitation from the herbal medicine and also offers favorable taste upon drinking.SOLUTION: A cold syrup containing an antipyretic analgesic, an antihistamine, an antitussive, and an expectorant, characterized by containing a herbal medicine and polyoxyethylene hydrogenated castor oil, wherein the herbal medicine contains at least one selected from the group consisting of Nandina fruit, Ephedra, and Platycodon root.SELECTED DRAWING: None

A hederasaponin composition and a hedera leaf extract. The hederasaponin composition comprises hederasaponin C, α-hederasaponin, hederasaponin B, and hederasaponin D in a mass ratio of 12-25:5-10:1:1-2. The hederasaponin composition and the hedera leaf extract can be used for preparing drugs for treating or preventing acute bronchitis, expectorants, and antitussives.

1. The name of the product of this design: Expectorant. 2. Purpose of this product with design: This product with design is used to assist in expectoration and is a medical care device. 3. The key point of the design of this product lies in its shape. 4. The picture or photo that best illustrates the design points: three-dimensional picture.

A formulation for oral administration comprises an expectorant, an analgesic, and at least one additional active ingredient having a modified release providing a therapeutic effect for each of the active ingredients for up to 12 hours.